Guanosine monophosphate, synthesis

Not all analogues become active against cancer cells through incorporation into nucleic acid. Some analogues block the synthesis of normal purine and pyrimidine nucleotides for example, 8-azaguanine blocks guanosine monophosphate (GMP) synthesis and 6-mercaptopurine inhibits adenosine monophosphate (AMP) syn-thesis. 

Figure 20.10 The positions in the pathway for de novo purine nucleotide synthesis where GLUCOSE provides the ribose molecule and GLUTAMINE provides nitrogen atoms. The pathway begins with glucose which provides ribose 5-phosphate, via the pentose phosphate pathway (Chapter 6). Glutamine provides its amide nitrogen in two reactions formation of 5-phosphoribosylamine and formation of guanosine monophosphate (GMP) from xantho-sine 5-phosphate (XMP).

Mycophenolate sodium (62 Myfortic Norvatis, 2003) is an immunosuppressant drug used to prevent rejection in organ transplantation. It is a selective, noncompetitive, reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme in the de novo pathway of guanosine nucleotide synthesis. Thus, mycophenolic acid (61), originally... 

Seelig, B., Jaschke, A. Ternary conjugates of guanosine monophosphate as initiator nucleotides for the enzymatic synthesis of 5/-modified RNAs. Bioconjugate Chem. 10, 371-378 (1999). 

Erection occurs when adrenergic-induced sinusoid tone is antagonized by sacral parasympathetic stimulation that produces sinusoidal relaxation primarily by synthesis and release of the nonadrenergic-noncholinergic (NANC) neurotransmitter nitric oxide (NO). The contribution of acetylcholine-dependent release of NO from the vascular endothelium is uncertain. In vitro electrical stimulation of isolated corpus cavemosum strips (with or without endothelium) produces sinusoidal relaxation by release of neurotransmitters within nerve terminals that is resistant to adrenergic and cholinergic blockers. Inhibitors of the synthesis of NO or of guanosine monophosphate (GMP),... 

This produces the first nucleotide in the synthesis of inosine monophosphate (IMP). Note that this is not merely a base, but is also a nucleotide IMP at the crossroads is an important precursor of other purine nucleotides. There are separate pathways to form guanosine monophosphates (GMP) and adenosine monophosphate (AMP). 

Figure 22.6 shows that IMP is a branch point for the synthesis of guanosine monophosphate (GMP) or adenosine monophosphate (AMP). Note that the enzyme catalyzing the pathway to make AMP is inhibited by AlMP and the enzyme catalyzing the pathway to make GMP is inhibited by GMP. Note, also, that energy requirements for the AlMP pathway are met by GTP whereas energy requirements for the GMP pathway are met by ATP. 

Two further natural product-derived immunosuppressants have been introduced recently, mycophenclate scdium and everclimus (Fig. 1.7) (44). The active principle of both mycophenolate sodium and an earlier introduced form, mycophenolate mofetil (a morpholinoethyl derivative), is mycophenolic acid, obtained from several Penicillium sp. This compound is a reversible inhibitor of inosine monophosphate dehydrogenase, which is involved in guanosine nucleotide synthesis (80). 

Cyclic nucleotides, 3, 5 -cyclic adenosine monophosphate (cAMP) and 3, 5 -cyclic guanosine monophosphate (cGMP), function to regulate cell-to-cell communication processes (33). Cellular communication follows primarily three pathways. The first involves the transmission of electrical impulses via the nervous system. The second involves chemical messengers or hormonal secretions. The third involves de novo protein synthesis. All three processes are usually in response to some demand or stimulus and involve, at least to some extent, regulation by cyclic nucleotides ... 

---